Ledger.Open graph →
SEC Form D · filed November 10, 2021

CND Life Sciences, Inc

Offering
$5.0M
Sold
$4.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHOENIX, AZ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Roy J. Freeman · Brookline, MADirectorEnrique J. Carrazana · Coral Gables, FLDirectorRichard J. Morello · Atlanta, GAExec · DirectorTodd J. Levine · Paradise Valley, AZDirectorPeter J. Harris · Brookline, MADirectorHaakon Overli · London, United KingdomExec · DirectorRobert Hartog · Denver, CODirectorC River LLC · Sacramento, CADirectorMatthew Shaw · London, United KingdomDirectorAlex Appleton · London, United KingdomDirectorTodd Sachse · Detroit, MIExec · DirectorRichard Broder · Detroit, MIDirectorMerredith Treaster · San Francisco, CADirectorCheryl R. Zabala · New York, NYDirectorAlexander M. Liang, M.D · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗